Join
Live feed
·
PRReleasevia Quantisnow
Organon & Co. logo

Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA

ByQuantisnow·Wall Street's wire, on your screen.
OGN· Organon & Co.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OGN (Organon & Co.) and more on Quantisnow.